Drugs / Taodan Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03942198 | Jun 2019 → Dec 2021 | psoriasis | Shanghai Yueyang Integrated Medicine Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Taodan Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03942198 ↗ |
| Known as | TDKL | “patients with psoriasis with blood-stasis syndrome treated with Taodan granules (TDKL).” PMID 31700924 ↗ Sep 2019 |